Company: INTS
Filing Date: 2025-05-13
Form Type: 10-Q
Source: 0001567264-25-000039
Chunk: 6

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-05-13
Form: 10-Q
Item: Part II, Item 1A
Chunk 6
---
Certification of CFO Pursuant to Section 302 of the Sarbanes-Oxley Act of 200232.1**Certification of CEO Pursuant to Section 906 of the Sarbanes-Oxley Act of 200232.2**Certification of CFO Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002101.INS*Inline XBRL Instance Document101.SCH*Inline XBRL Taxonomy Extension Schema Document.101.CAL*Inline XBRL Taxonomy Extension Calculation Linkbase Document.101.DEF*Inline XBRL Taxonomy Extension Definition Linkbase Document.101.LAB*Inline XBRL Taxonomy Extension Label Linkbase Document.101.PRE*Inline XBRL Taxonomy Extension Presentation Linkbase Document.104*Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

______________________________________

*   Filed herewith.

** Furnished herewith.

# Indicates a management contract or compensatory plan or arrangement.

24

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

Intensity Therapeutics, Inc.Date: May 13, 2025By:/s/ Lewis H. BenderLewis H. BenderPresident, Chief Executive Officer and Chairman

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

NameTitleDate/s/ Lewis H. BenderPresident, Chief Executive Officer and ChairmanMay 13, 2025Lewis H. Bender(principal executive officer)/s/ Joseph TalamoChief Financial OfficerMay 13, 2025Joseph Talamo(principal financial officer)

25